KORTHOS / ECOSYSTEM / PRODUCT

CMR Surgical Versius Plus

About

About CMR Surgical Versius Plus

CMR Surgical Versius Plus is a modular robotic-assisted surgical system for minimally invasive soft-tissue procedures. Its separate portable arm units can be positioned around the operating table and the surgeon works from an open console, preserving communication with the bedside team. The system combines fully wristed instruments, 3D HD vision and optional vLimeLite fluorescence imaging with apps that track procedure logs, utilisation and operating performance.

Versius Plus is CMR’s second-generation platform and its commercial scope varies by jurisdiction. In the United States it received FDA 510(k) clearance in December 2025 for cholecystectomy in adults aged 22 and older; CMR filed a separate gynecology submission in April 2026. The modular architecture lets hospitals use only the arms required for a procedure and move the system between operating rooms.

18 OCT 2026

Physical AI capital moves — 12–18 October 2026

15 OCT 2026

Stryker agrees $400M investment and US Versius sales alliance with CMR Surgical

Capabilities

Source-backed capabilities

  • Workflows: Surgical robot platform
  • Target markets: Medical robotics domain
  • Robot-assisted surgery

    Demonstrated - 2026-07-22 - CMR planned to showcase the simulation at the Society of Robotic Surgery conference in Florida on July 23–26, 2026.

    Source

Timeline

  • CMR Surgical announces an NVIDIA simulation workflow for Versius Plus

    2026-07-22 - Demonstration - The workflow uses NVIDIA Isaac for Healthcare’s Medical Physics Simulation framework and Cosmos-H-Dreams. CMR planned to showcase the simulation at the Society of Robotic Surgery conference in Florida on July 23–26, 2026. The simulation is for research and demonstration only and is not part of the currently cleared Versius Plus system or intended for clinical decision-making.

    Source
  • FDA records an open Class II recall for two Versius surgeon consoles

    2026-07-09 - Regulatory - The recall covers two V-SS-1020 consoles running Pratchett 1 version 62.1 that were distributed in California. The firm initiated the recall on June 9, 2026 and the corrective action is to notify customers and configure secure boot on the affected consoles. Updated instructions tell users to keep the system in a secure environment and inspect tamper-evident labels before use.

    Source
  • CMR Surgical submits Versius Plus 510(k) for benign gynecology

    2026-04-29 - Regulatory - The submission seeks clearance for benign procedures including total hysterectomy, oophorectomy and salpingectomy. CMR said the filing builds on global clinical experience and supports its U.S. market expansion. This is a premarket submission, not an FDA clearance; Versius Plus was previously cleared for adult cholecystectomy.

    Source
  • FDA clears Versius Plus for adult cholecystectomy

    2025-12-16 - Regulatory - The clearance covers robotically assisted cholecystectomy in adults aged 22 and older. Versius Plus remains surgeon-controlled and uses modular bedside arm units with an open console. CMR said U.S. commercialisation would begin in 2026.

    Source

Context

Comparable Systems